GERM vs. QDVO
GERM (Amplify Treatments, Testing and Advancements ETF) and QDVO (Amplify CWP Growth & Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while QDVO is a Derivative Income fund actively managed by Amplify. GERM is passively managed, while QDVO is actively managed. Over the past year, GERM returned 0.00% vs 21.13% for QDVO. GERM charges 0.68%/yr vs 0.56%/yr for QDVO.
Performance
GERM vs. QDVO - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
QDVO
- 1D
- -1.31%
- 1M
- -3.62%
- YTD
- 5.51%
- 6M
- 4.58%
- 1Y
- 21.13%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM vs. QDVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
QDVO Amplify CWP Growth & Income ETF | 5.51% | 20.16% | 13.67% |
GERM vs. QDVO - Sectors Allocation Comparison
Sectors
GERM
QDVO
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
GERM
QDVO
Financial Services
GERM
QDVO
Basic Materials
GERM
-
QDVO
Communication Services
GERM
-
QDVO
Consumer Cyclical
GERM
-
QDVO
Consumer Defensive
GERM
-
QDVO
Energy
GERM
-
QDVO
Industrials
GERM
-
QDVO
Real Estate
GERM
-
QDVO
-
Technology
GERM
-
QDVO
Utilities
GERM
-
QDVO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. QDVO — Risk / Return Rank
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
QDVO
GERM vs. QDVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify CWP Growth & Income ETF (QDVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | QDVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.30 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.08 | — |
| Martin ratioReturn relative to average drawdown | — | 8.08 | — |
Loading charts...
Drawdowns
GERM vs. QDVO - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum QDVO drawdown of -17.75%. Use the drawdown chart below to compare losses from any high point for GERM and QDVO.
Loading charts...
Drawdown Indicators
| GERM | QDVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -17.75% | +17.75% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -10.21% | +10.21% |
Current DrawdownCurrent decline from peak | 0.00% | -4.81% | +4.81% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -2.41% | +2.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 2.62% | -2.62% |
Volatility
GERM vs. QDVO - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify CWP Growth & Income ETF (QDVO) has a volatility of 4.47%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than QDVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | QDVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 4.47% | -4.47% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 9.59% | -9.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 12.69% | -12.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 17.54% | -17.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 17.54% | -17.54% |
GERM vs. QDVO - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than QDVO's 0.56% expense ratio.
Dividends
GERM vs. QDVO - Dividend Comparison
GERM has not paid dividends to shareholders, while QDVO's dividend yield for the trailing twelve months is around 10.53%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
QDVO Amplify CWP Growth & Income ETF | 10.53% | 9.92% | 2.79% |
Frequently Asked Questions
QDVO has higher volatility (4.47%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs QDVO's -17.75%.
On 1-year performance, QDVO leads with 21.13% vs 0.00% for GERM. On fees, QDVO is cheaper at 0.56% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, QDVO has performed better with a 21.13% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QDVO is cheaper with a 0.56% expense ratio, compared with 0.68% for GERM.
QDVO has the higher dividend yield at 10.53%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while QDVO is Derivative Income. Their fees differ too: 0.68% for GERM and 0.56% for QDVO.
Find the right allocation for GERM and QDVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer